Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Open
Phase 2
This trial is comparing venetoclax and low dose cytarabine with intensive chemotherapy. It is for people with acute myeloid leukaemia aged 55 years and older. And who have a certain change () called NPM1.
Cancer Research UK supports this trial.
Recruitment start: 1 June 2021
Recruitment end: 1 June 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Richard Dillon
Cancer Research UK
University of Birmingham
This is Cancer Research UK trial number CRUK/19/013.
Last reviewed: 22 May 2025
CRUK internal database number: 17181
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
